» Articles » PMID: 27255725

Central Role of P2Y6 UDP Receptor in Arteriolar Myogenic Tone

Abstract

Objective: Myogenic tone (MT) of resistance arteries ensures autoregulation of blood flow in organs and relies on the intrinsic property of smooth muscle to contract in response to stretch. Nucleotides released by mechanical strain on cells are responsible for pleiotropic vascular effects, including vasoconstriction. Here, we evaluated the contribution of extracellular nucleotides to MT.

Approach And Results: We measured MT and the associated pathway in mouse mesenteric resistance arteries using arteriography for small arteries and molecular biology. Of the P2 receptors in mouse mesenteric resistance arteries, mRNA expression of P2X1 and P2Y6 was dominant. P2Y6 fully sustained UDP/UTP-induced contraction (abrogated in P2ry6(-/-) arteries). Preventing nucleotide hydrolysis with the ectonucleotidase inhibitor ARL67156 enhanced pressure-induced MT by 20%, whereas P2Y6 receptor blockade blunted MT in mouse mesenteric resistance arteries and human subcutaneous arteries. Despite normal hemodynamic parameters, P2ry6(-/-) mice were protected against MT elevation in myocardial infarction-induced heart failure. Although both P2Y6 and P2Y2 receptors contributed to calcium mobilization, P2Y6 activation was mandatory for RhoA-GTP binding, myosin light chain, P42-P44, and c-Jun N-terminal kinase phosphorylation in arterial smooth muscle cells. In accordance with the opening of a nucleotide conduit in pressurized arteries, MT was altered by hemichannel pharmacological inhibitors and impaired in Cx43(+/-) and P2rx7(-/-) mesenteric resistance arteries.

Conclusions: Signaling through P2 nucleotide receptors contributes to MT. This mechanism encompasses the release of nucleotides coupled to specific autocrine/paracrine activation of the uracil nucleotide P2Y6 receptor and may contribute to impaired tissue perfusion in cardiovascular diseases.

Citing Articles

Cytokine Adsorption During Ex Vivo Blood Perfusion Improves Contractility of Donation After Circulatory Death Hearts.

Saemann L, Pohl S, Wachter K, Georgevici A, Kohler C, Junger J J Am Heart Assoc. 2024; 13(23):e036872.

PMID: 39575707 PMC: 11681589. DOI: 10.1161/JAHA.124.036872.


The P2Y6 Receptor as a Potential Keystone in Essential Hypertension.

Daghbouche-Rubio N, Alvarez-Miguel I, Flores V, Rojo-Mencia J, Navedo M, Nieves-Citron M Function (Oxf). 2024; 5(6).

PMID: 39322240 PMC: 11577605. DOI: 10.1093/function/zqae045.


The microglial P2Y receptor as a therapeutic target for neurodegenerative diseases.

Dundee J, Brown G Transl Neurodegener. 2024; 13(1):47.

PMID: 39243044 PMC: 11380353. DOI: 10.1186/s40035-024-00438-5.


Functionalized Congeners of 2-Chromene P2Y Receptor Antagonists.

Oliva P, Pramanik A, Jung Y, Lewicki S, Mwendwa J, Park J Cells. 2024; 13(16).

PMID: 39195256 PMC: 11352859. DOI: 10.3390/cells13161366.


How selective antagonists and genetic modification have helped characterise the expression and functions of vascular P2Y receptors.

Dales M, Drummond R, Kennedy C Purinergic Signal. 2024; .

PMID: 38740733 DOI: 10.1007/s11302-024-10016-z.


References
1.
Fortes F, Pecora I, Persechini P, Hurtado S, Costa V, Coutinho-Silva R . Modulation of intercellular communication in macrophages: possible interactions between GAP junctions and P2 receptors. J Cell Sci. 2004; 117(Pt 20):4717-26. DOI: 10.1242/jcs.01345. View

2.
Wang N, Butler J, Ingber D . Mechanotransduction across the cell surface and through the cytoskeleton. Science. 1993; 260(5111):1124-7. DOI: 10.1126/science.7684161. View

3.
Lazarowski E, Boucher R, Harden T . Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules. Mol Pharmacol. 2003; 64(4):785-95. DOI: 10.1124/mol.64.4.785. View

4.
Kauffenstein G, Drouin A, Thorin-Trescases N, Bachelard H, Robaye B, DOrleans-Juste P . NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse. Cardiovasc Res. 2009; 85(1):204-13. PMC: 3694873. DOI: 10.1093/cvr/cvp265. View

5.
Praetorius H, Leipziger J . ATP release from non-excitable cells. Purinergic Signal. 2009; 5(4):433-46. PMC: 2776134. DOI: 10.1007/s11302-009-9146-2. View